Jiayuan Science and Technology Co.,Ltd. (SHE:301117)
China · Delayed Price · Currency is CNY 50.80
-0.80 (-1.55%)
At close: Feb 13, 2026
SHE:301117 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 330.15 | 321.93 | 227.39 | 269.52 | 316.84 | 190.56 |
Other Revenue | 14.87 | 14.87 | - | - | - | - |
| 345.01 | 336.8 | 227.39 | 269.52 | 316.84 | 190.56 | |
Revenue Growth (YoY) | 46.23% | 48.11% | -15.63% | -14.94% | 66.27% | 45.45% |
Cost of Revenue | 194.23 | 191.57 | 118.08 | 120.02 | 147.6 | 91.38 |
Gross Profit | 150.79 | 145.23 | 109.31 | 149.5 | 169.24 | 99.18 |
Selling, General & Admin | 57.65 | 61.25 | 57.13 | 35.38 | 21.15 | 16.03 |
Research & Development | 61.86 | 63.07 | 63.22 | 50.23 | 28.8 | 12.72 |
Other Operating Expenses | 2.3 | 1.66 | 1.01 | -0.68 | 2.44 | 0.72 |
Operating Expenses | 135.84 | 148.41 | 133.37 | 94.59 | 63.96 | 37.05 |
Operating Income | 14.95 | -3.18 | -24.06 | 54.9 | 105.28 | 62.13 |
Interest Expense | -1.7 | -0.82 | -0.33 | -1.36 | -2 | -0.61 |
Interest & Investment Income | 4.56 | 9.22 | 15.02 | 17.41 | 0.1 | 0.08 |
Currency Exchange Gain (Loss) | 0.03 | 0.03 | -0.02 | - | - | - |
Other Non Operating Income (Expenses) | -1.07 | -0.16 | -0.78 | 0.02 | -1.65 | -1.45 |
EBT Excluding Unusual Items | 16.76 | 5.07 | -10.18 | 70.97 | 101.72 | 60.14 |
Impairment of Goodwill | -2.76 | -2.76 | - | - | - | - |
Gain (Loss) on Sale of Investments | 0.07 | 0.07 | 1.22 | - | - | - |
Gain (Loss) on Sale of Assets | 0.02 | - | -0 | -0 | - | -0 |
Asset Writedown | -0.93 | -0.22 | - | - | - | - |
Other Unusual Items | 5.47 | 5.47 | -0.14 | -4.06 | 4.7 | 0.69 |
Pretax Income | 18.64 | 7.63 | -9.1 | 66.9 | 106.42 | 60.83 |
Income Tax Expense | -1.03 | -3.54 | -3.31 | 5.5 | 13.33 | 7.96 |
Earnings From Continuing Operations | 19.66 | 11.17 | -5.79 | 61.4 | 93.09 | 52.87 |
Minority Interest in Earnings | 0.07 | 0.27 | 0.43 | 0.17 | -0.59 | -0.22 |
Net Income | 19.73 | 11.45 | -5.35 | 61.57 | 92.5 | 52.65 |
Net Income to Common | 19.73 | 11.45 | -5.35 | 61.57 | 92.5 | 52.65 |
Net Income Growth | - | - | - | -33.43% | 75.68% | 66.24% |
Shares Outstanding (Basic) | 140 | 134 | 125 | 127 | 97 | 97 |
Shares Outstanding (Diluted) | 140 | 134 | 125 | 127 | 97 | 97 |
Shares Change (YoY) | 13.71% | 7.03% | -1.58% | 31.17% | -0.35% | 4.96% |
EPS (Basic) | 0.14 | 0.09 | -0.04 | 0.49 | 0.96 | 0.54 |
EPS (Diluted) | 0.14 | 0.09 | -0.04 | 0.49 | 0.96 | 0.54 |
EPS Growth | - | - | - | -49.25% | 76.29% | 58.38% |
Free Cash Flow | -186.98 | -177.96 | -97.79 | -226.3 | -53.17 | -2.56 |
Free Cash Flow Per Share | -1.33 | -1.33 | -0.78 | -1.78 | -0.55 | -0.03 |
Dividend Per Share | 0.014 | 0.014 | - | 0.107 | 0.286 | - |
Dividend Growth | - | - | - | -62.51% | - | - |
Gross Margin | 43.70% | 43.12% | 48.07% | 55.47% | 53.41% | 52.05% |
Operating Margin | 4.33% | -0.95% | -10.58% | 20.37% | 33.23% | 32.60% |
Profit Margin | 5.72% | 3.40% | -2.35% | 22.85% | 29.20% | 27.63% |
Free Cash Flow Margin | -54.20% | -52.84% | -43.00% | -83.96% | -16.78% | -1.34% |
EBITDA | 41.49 | 14.55 | -18.06 | 55.85 | 106.12 | 62.64 |
EBITDA Margin | 12.03% | 4.32% | -7.94% | 20.72% | 33.50% | 32.87% |
D&A For EBITDA | 26.54 | 17.74 | 6 | 0.95 | 0.85 | 0.51 |
EBIT | 14.95 | -3.18 | -24.06 | 54.9 | 105.28 | 62.13 |
EBIT Margin | 4.33% | -0.95% | -10.58% | 20.37% | 33.23% | 32.60% |
Effective Tax Rate | - | - | - | 8.22% | 12.53% | 13.09% |
Revenue as Reported | 345.01 | 336.8 | 227.39 | 269.52 | 316.84 | 190.56 |
Advertising Expenses | - | 0.06 | 0.53 | 0 | - | - |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.